AI-generated content for informational purposes only. Not financial advice. Always do your own research.

Chi siamo

Clorox produce e commercializza prodotti per la pulizia, per la casa e lifestyle sotto marchi affidabili tra cui Clorox bleach, Pine-Sol, Glad, Burt Bees e Hidden Valley ranch dressing. L'azienda occupa posizioni di mercato forti in categorie dove la fiducia nel marchio e l'efficacia guidano la fedeltà dei consumatori e gli acquisti ripetuti. Gli investitori difensivi e quelli focalizzati sui dividendi favoriscono Clorox per le sue linee di prodotti resistenti alle recessioni e per il suo impegno nel restituire capitale agli azionisti.

Azioni con Dividendo

Clorox ha pagato dividendi per decenni e ha aumentato costantemente il suo payout, rendendola un generatore di reddito affidabile sostenuto dalla natura essenziale del suo portafoglio di prodotti per la pulizia e la casa.

Azioni del commercio al dettaglio

I prodotti Clorox sono venduti in praticamente ogni negozio di alimentari e rivendita di massa negli Stati Uniti, con nomi di marca come Clorox, Glad e Pine-Sol che dominano le rispettive categorie di pulizia e articoli per la casa.

Azioni Value

Clorox è scambiata al di sotto della sua gamma di valutazione storica a seguito di interruzioni dovute a attacchi informatici e pressioni sui costi dei materiali, presentando una potenziale opportunità di valore per gli investitori pazienti mentre i margini si normalizzano e le operazioni si riprendono.

Key Financials CLX

Prezzo $125.94
Variazione (1G) +1.04%
Variazione (30D) +24.90%
Variazione (60D) +24.43%
Variazione (90D) +6.13%
Variazione (180D) -3.24%
Variazione (1Y) -15.28%
Variazione (5Y) -32.78%
P/E Ratio 58.31
EPS (TTM) $2.16
Range a 52 settimane $96.66 — $159.04
MA a 50 giorni $107.76
Volume 1.53M

Data updated Feb 15 · Source: Twelve Data

3.5
2 reviews
Dividend Yield
3.8
Dividend Growth
3.5
Financial Stability
2.8
Payout Ratio
2.5
Sector Performance
1.8
Claude Opus 4.6
AI Review
3.0/5

Clorox is a well-known consumer staples company with iconic brands including its namesake bleach, Glad, Burt's Bees, and Hidden Valley. However, the investment case is challenging at current levels. The stock has declined 32.78% over five years, significantly underperforming the broader market, reflecting post-pandemic demand normalization and a damaging 2023 cyberattack that disrupted operations.

The P/E ratio of 58.31 is extremely elevated for a mature consumer products company, driven by depressed trailing EPS of just $2.16. While earnings are recovering, this valuation leaves little margin of safety. The recent 24.9% monthly bounce suggests improving sentiment, but the stock remains well below its 52-week high of $159.04.

On the bull side, Clorox maintains a reliable dividend with decades of increases, strong brand recognition, and defensive characteristics. The bear case centers on premium valuation, sluggish organic growth, private-label competition, and input cost pressures. As a dividend stock, the yield remains attractive but payout sustainability warrants monitoring given compressed earnings. Value investors should wait for a more compelling entry point.

Dividend Yield
3.8
Dividend Growth
3.5
Financial Stability
2.8
Payout Ratio
2.5
Sector Performance
1.8
Feb 15, 2026
Gemini 3 Pro Preview
AI Review
4.0/5

Clorox (CLX) stands as a resilient consumer staple giant, anchoring portfolios with its Dividend Aristocrat status and a diverse family of market-leading brands like Glad, Kingsford, and Burt's Bees. The stock is currently in a recovery phase following significant operational disruptions caused by a 2023 cyberattack, which explains the unusually high trailing P/E ratio of 58.31 relative to historical norms.

For dividend investors, Clorox remains attractive due to its unwavering commitment to shareholder returns and defensive characteristics during economic uncertainty. However, the current valuation demands scrutiny; investors are essentially paying for a rebound in earnings power rather than current performance. While the brand equity is undeniable, potential headwinds include input cost volatility and consumer shifting toward private-label products. CLX is best suited for long-term income investors willing to look past near-term volatility as operations normalize.

Feb 12, 2026
Clorox Screenshot

Added: Feb 11, 2026

thecloroxcompany.com

Latest from Otrai

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

A stock index is a single number that summarizes the price action of a basket of companies. The S&P 500 tracks roughly 500 large US firms, the Nasdaq-100 tracks the 100 largest non-financial names on the Nasdaq exchange, and the Dow Jones Industrial Average follows 30 blue-chip stocks.

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Greeks explain why an option costs what it costs and how that price changes when the stock moves, time passes, and volatility shifts. Delta, Gamma, Theta, and Vega, made accessible.

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart patterns are the most recognizable part of technical analysis and the most misunderstood. Most fail or break out the wrong way before reversing. This guide covers head and shoulders, double tops and bottoms, triangles, and flags — with realistic reliability, target measurement, and false-breakout confirmation.

Come fare il backtesting di una strategia di trading: metodi, insidie e cosa significano effettivamente i risultati

Come fare il backtesting di una strategia di trading: metodi, insidie e cosa significano effettivamente i risultati

Ogni trader ha una strategia che sembra fantastica nella sua testa. Il backtesting è il modo per scoprire se effettivamente funziona. Ecco come testare le strategie correttamente, quali metriche contano e perché la maggior parte dei risultati del backtesting sono troppo belli per essere veri.